Efficacy of pitavastatin on HDL-cholesterol
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.45, ss.5-7, 2017 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 45
- Basım Tarihi: 2017
- Doi Numarası: 10.5543/tkda.2017.24524
- Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.5-7
- Hacettepe Üniversitesi Adresli: Evet
Özet
Epidemiological studies have shown that low HDL predicts cardiovascular risk just as much as elevated LDL cholesterol levels. However, today we know that HDL functionality is more important than HDL levels. As a group effect, statins increase HDL levels. They are also thought to increase functional HDL. Pitavastatin is a new statin with a different structure, shown to increase HDL levels more than other statins as well as functionality. Studies have shown that plaque regression occurs with pitavastatin. These findings provide the expectation that it will also decrease cardiovascular events.